Clinical Trials in Atlanta

Showing 1701-1720 of 19,805 trials

TBI Evaluation and Management (TEaM)

NCT04576715

The purpose of this study is to evaluate a multi-disciplinary, multi-setting intervention with the goal of improving outcomes for children who have experienced a mild traumatic brain injury (mTBI). The project aims to improve and support mTBI diagnosis and management, and improve critical decision making by clinicians during their interaction with the injured child, their family, and their school.

Mild Traumatic Brain Injury

Emory University101 participantsStarted Aug 2022

Atlanta, Georgia, United States • Atlanta, Georgia, United States • Atlanta, Georgia, United States

Active Not RecruitingPhase 2< 1 mile

Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer

NCT04001829

This phase II trial studies whether a prior germline predictor of taxane-induced peripheral neuropathy (TIPN) can help identify a subgroup of patients who are at higher risk of chemotherapy-induced peripheral neuropathy in African American patients with stages I-III breast cancer. The study also investigates whether docetaxel maybe work better than paclitaxel with regard to TIPN rate/severity and dose reductions.

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+18 more

ECOG-ACRIN Cancer Research Group249 participantsStarted Aug 2019

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Anchorage, Alaska, United States +482 more locations

TBI Evaluation and Management (TEaM)

Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer

Find Trials by Condition in Atlanta

A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer

Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants

TITAN™ Reverse Shoulder System

EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma

Terumo Aortic Global Endovascular Registry

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors

Optimizing Reperfusion to Improve Outcomes and Neurologic Function

A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer